WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

Neuralink competitor Paradromics just implanted its first brain-chip device. Next is restoring speech.

Paradromics CEO Matt Angle said the patient will start testing the device in the coming weeks with the goal of restoring her ability to communicate.

Raccontata dathenextweb.combusinessinsider.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
businessinsider.comStai leggendo5 h fa

Neuralink competitor Paradromics just implanted its first brain-chip device. Next is restoring speech.

Paradromics CEO Matt Angle said the patient will start testing the device in the coming weeks with the goal of restoring her ability to communicate.

originale
thenextweb.com7 h fa

Paradromics implants brain chip in its first patient

Neuralink rival Paradromics has implanted its Connexus brain chip in a woman who lost her speech to motor neuron disease, the first patient in its FDA study.

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 17 giugno 2026·thenextweb.com

    Paradromics implants brain chip in its first patient

    Neuralink rival Paradromics has implanted its Connexus brain chip in a woman who lost her speech to motor neuron disease, the first patient in its FDA study.

  2. mercoledì 17 giugno 2026·businessinsider.com

    Neuralink competitor Paradromics just implanted its first brain-chip device. Next is restoring speech.

    Paradromics CEO Matt Angle said the patient will start testing the device in the coming weeks with the goal of restoring her ability to communicate.